1. Home
  2. STG vs SKYE Comparison

STG vs SKYE Comparison

Compare STG & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STG
  • SKYE
  • Stock Information
  • Founded
  • STG 2003
  • SKYE 2012
  • Country
  • STG China
  • SKYE United States
  • Employees
  • STG N/A
  • SKYE N/A
  • Industry
  • STG Other Consumer Services
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • STG Real Estate
  • SKYE Health Care
  • Exchange
  • STG Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • STG 91.6M
  • SKYE 80.7M
  • IPO Year
  • STG 2018
  • SKYE N/A
  • Fundamental
  • Price
  • STG $6.78
  • SKYE $3.06
  • Analyst Decision
  • STG
  • SKYE Buy
  • Analyst Count
  • STG 0
  • SKYE 6
  • Target Price
  • STG N/A
  • SKYE $18.67
  • AVG Volume (30 Days)
  • STG 8.9K
  • SKYE 207.1K
  • Earning Date
  • STG 03-21-2025
  • SKYE 02-18-2025
  • Dividend Yield
  • STG N/A
  • SKYE N/A
  • EPS Growth
  • STG N/A
  • SKYE N/A
  • EPS
  • STG 4.57
  • SKYE N/A
  • Revenue
  • STG $292,030,936.00
  • SKYE N/A
  • Revenue This Year
  • STG N/A
  • SKYE N/A
  • Revenue Next Year
  • STG N/A
  • SKYE N/A
  • P/E Ratio
  • STG $1.48
  • SKYE N/A
  • Revenue Growth
  • STG N/A
  • SKYE N/A
  • 52 Week Low
  • STG $4.25
  • SKYE $2.31
  • 52 Week High
  • STG $12.55
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • STG 55.98
  • SKYE 50.73
  • Support Level
  • STG $6.51
  • SKYE $2.60
  • Resistance Level
  • STG $6.92
  • SKYE $3.54
  • Average True Range (ATR)
  • STG 0.20
  • SKYE 0.49
  • MACD
  • STG 0.02
  • SKYE 0.02
  • Stochastic Oscillator
  • STG 60.09
  • SKYE 30.81

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: